Close X
Sunday, November 10, 2024
ADVT 
International

US announces additional H-2B visas for FY 2024

Darpan News Desk IANS, 20 Nov, 2023 12:51 PM
  • US announces additional H-2B visas for FY 2024

New York, Nov 20 (IANS) The US Departments of Labor and Homeland Security have announced an additional 64,716 H-2B temporary non-agricultural worker visas for FY 2024.

This allotment is in addition to the Congressionally-mandated 66,000 H-2B visas that are available each fiscal year, and permits employers to temporarily hire non-citizens to plug worker shortages in the US.

"By making these supplemental visas available at the outset of FY 2024, the Departments will help ensure US businesses with workforce needs are able to plan ahead and find the seasonal and temporary workers they need," the US Citizenship and Immigration Services (USCIS) announced this week.

The H-2B supplemental includes an allocation of 20,000 visas to workers from Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Haiti, and Honduras.

In addition to the 20,000 country-specific allocation, 44,716 supplemental visas are available to returning workers who received H-2B visas, or were otherwise granted H-2B status during one of the last three fiscal years.

The rule allocates these supplemental visas for returning workers between the first half and second half of the fiscal year to account for the need for additional seasonal and other temporary workers over the course of the year, with a portion of the second half allocation reserved to meet the demand for workers during the summer season.

The semiannual cap of 33,000 H-2B visas authorised under the Immigration and Nationality Act (statutory cap) for the first half of FY 2024 was reached on October 11, 2023.

These supplemental visas are available only to the US businesses that are suffering irreparable harm or will suffer impending irreparable harm without the ability to employ all the H-2B workers requested in their petition, as attested by the employer on a new attestation form.

MORE International ARTICLES

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

China permits Indian students to return on 'need-assessed' basis

China permits Indian students to return on 'need-assessed' basis
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.

China permits Indian students to return on 'need-assessed' basis